Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IDXX IDEXX Laboratories	$653.95 -1.5%	$553.29	$356.14 ▼ $688.12	$52.32B	1.49	734,255 shs	504,662 shs
ISRG Intuitive Surgical	$477.08 -1.1%	$511.91	$425.00 ▼ $616.00	$171.02B	1.59	2.00 million shs	1.89 million shs
LGV Longview Acquisition Corp. II	$10.09	$10.09	$9.68 ▼ $10.15	N/A	N/A	N/A	N/A
TMO Thermo Fisher Scientific	$485.62 +0.2%	$431.32	$385.46 ▼ $627.88	$183.38B	0.74	2.50 million shs	1.96 million shs

These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IDXX IDEXX Laboratories	+1.79%	+6.37%	+24.93%	+29.67%	+36.10%
ISRG Intuitive Surgical	+0.87%	+1.75%	-6.60%	-13.91%	+2.80%
LGV Longview Acquisition Corp. II	0.00%	0.00%	0.00%	0.00%	0.00%
TMO Thermo Fisher Scientific	+1.63%	+8.02%	+14.17%	+20.15%	-19.61%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
IDXX IDEXX Laboratories	4.3258 of 5 stars	2.4	4.0	0.0	3.7	4.0	2.5	1.3
ISRG Intuitive Surgical	4.7122 of 5 stars	3.3	3.0	0.0	4.0	4.2	2.5	1.9
LGV Longview Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TMO Thermo Fisher Scientific	4.9624 of 5 stars	3.4	4.0	2.5	4.1	4.2	2.5	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
IDXX IDEXX Laboratories	2.80	Moderate Buy	$644.67	-1.42% Downside
ISRG Intuitive Surgical	2.63	Moderate Buy	$595.95	24.92% Upside
LGV Longview Acquisition Corp. II	0.00	N/A	N/A	N/A
TMO Thermo Fisher Scientific	2.71	Moderate Buy	$593.00	22.11% Upside

Current Analyst Ratings Breakdown

Latest LGV, TMO, ISRG, and IDXX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/11/2025	IDXX IDEXX Laboratories	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$510.00 ➝ $700.00
8/5/2025	IDXX IDEXX Laboratories	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Overweight ➝ Overweight	$722.00
8/5/2025	IDXX IDEXX Laboratories	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$545.00 ➝ $785.00
8/4/2025	IDXX IDEXX Laboratories	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$640.00
8/4/2025	IDXX IDEXX Laboratories	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$550.00 ➝ $675.00
7/24/2025	TMO Thermo Fisher Scientific	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/24/2025	TMO Thermo Fisher Scientific	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$460.00 ➝ $500.00
7/24/2025	TMO Thermo Fisher Scientific	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$525.00 ➝ $535.00
7/24/2025	TMO Thermo Fisher Scientific	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$570.00 ➝ $565.00
7/24/2025	TMO Thermo Fisher Scientific	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$510.00
7/24/2025	TMO Thermo Fisher Scientific	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$450.00 ➝ $490.00

(Data available from 8/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
IDXX IDEXX Laboratories	$4.04B	12.96	$12.46 per share	52.48	$18.23 per share	35.87
ISRG Intuitive Surgical	$8.35B	20.48	$7.97 per share	59.86	$50.08 per share	9.53
LGV Longview Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A	N/A
TMO Thermo Fisher Scientific	$43.21B	4.24	$30.54 per share	15.90	$133.67 per share	3.63

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
IDXX IDEXX Laboratories	$887.87M	$12.01	54.45	48.16	4.22	24.41%	64.42%	29.89%	10/30/2025 (Estimated)
ISRG Intuitive Surgical	$2.32B	$7.17	66.54	62.53	5.01	28.51%	14.56%	12.93%	10/16/2025 (Estimated)
LGV Longview Acquisition Corp. II	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
TMO Thermo Fisher Scientific	$6.34B	$17.29	28.09	19.00	2.55	15.24%	16.82%	8.38%	10/22/2025 (Estimated)

Latest LGV, TMO, ISRG, and IDXX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/4/2025	Q2 2025	IDXX IDEXX Laboratories	$3.28	$3.63	+$0.35	$3.63	$1.06 billion	$1.11 billion
7/23/2025	Q2 2025	TMO Thermo Fisher Scientific	$5.22	$5.36	+$0.14	$4.28	$10.68 billion	$10.86 billion
7/22/2025	Q2 2025	ISRG Intuitive Surgical	$1.93	$2.19	+$0.26	$1.81	$2.35 billion	$2.44 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
IDXX IDEXX Laboratories	N/A	N/A	N/A	N/A	N/A
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
LGV Longview Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A
TMO Thermo Fisher Scientific	$1.72	0.35%	N/A	9.95%	8 Years

Latest LGV, TMO, ISRG, and IDXX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/10/2025	TMO Thermo Fisher Scientific	quarterly	$0.43	0.4%	9/15/2025	9/15/2025	10/15/2025
5/21/2025	TMO Thermo Fisher Scientific	quarterly	$0.43	0.43%	6/13/2025	6/13/2025	7/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
IDXX IDEXX Laboratories	0.31	1.11	0.79
ISRG Intuitive Surgical	N/A	5.17	4.18
LGV Longview Acquisition Corp. II	N/A	N/A	N/A
TMO Thermo Fisher Scientific	0.65	1.93	1.50

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
IDXX IDEXX Laboratories	87.84%
ISRG Intuitive Surgical	83.64%
LGV Longview Acquisition Corp. II	N/A
TMO Thermo Fisher Scientific	89.23%

Insider Ownership

Company	Insider Ownership
IDXX IDEXX Laboratories	0.98%
ISRG Intuitive Surgical	0.70%
LGV Longview Acquisition Corp. II	26.35%
TMO Thermo Fisher Scientific	0.33%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
IDXX IDEXX Laboratories	11,000	80.01 million	79.22 million	Optionable
ISRG Intuitive Surgical	15,638	358.48 million	355.97 million	Optionable
LGV Longview Acquisition Corp. II	3	N/A	N/A	Not Optionable
TMO Thermo Fisher Scientific	125,000	377.61 million	376.37 million	Optionable

LGV, TMO, ISRG, and IDXX Headlines

Recent News About These Companies

E Fund Management Co. Ltd. Purchases 680 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

August 14 at 7:31 AM | marketbeat.com

Tokio Marine Asset Management Co. Ltd. Increases Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

August 14 at 7:17 AM | marketbeat.com

Triglav Skladi D.O.O. Has $12.51 Million Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

August 14 at 7:06 AM | marketbeat.com

S Bank Fund Management Ltd Purchases New Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

August 14 at 6:51 AM | marketbeat.com

Gulf International Bank UK Ltd Has $10.99 Million Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

August 14 at 6:50 AM | marketbeat.com

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by National Pension Service

August 14 at 6:47 AM | marketbeat.com

Klingman & Associates LLC Decreases Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

August 14 at 6:38 AM | marketbeat.com

GKV Capital Management Co. Inc. Has $302,000 Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

August 14 at 6:27 AM | marketbeat.com

Mondrian Investment Partners LTD Has $106.74 Million Stake in Thermo Fisher Scientific Inc. (NYSE:TMO)

August 14 at 6:16 AM | marketbeat.com

Westpac Banking Corp Reduces Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

August 14 at 5:57 AM | marketbeat.com

HighTower Advisors LLC Buys 1,714 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

August 14 at 5:38 AM | marketbeat.com

LGT Fund Management Co Ltd. Has $3.51 Million Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

August 13 at 7:21 AM | marketbeat.com

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Russell Investments Group Ltd.

August 13 at 7:04 AM | marketbeat.com

Resona Asset Management Co. Ltd. Has $59.15 Million Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

August 13 at 6:54 AM | marketbeat.com

Rathbones Group PLC Buys 45,673 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

August 13 at 6:46 AM | marketbeat.com

Iyo Bank Ltd. Buys 4,140 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

August 13 at 6:45 AM | marketbeat.com

Callan Family Office LLC Decreases Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

August 13 at 6:37 AM | marketbeat.com

Nuance Investments LLC Sells 1,428 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

August 13 at 6:16 AM | marketbeat.com

Trillium Asset Management LLC Has $39.94 Million Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

August 13 at 5:53 AM | marketbeat.com

Thermo Fisher Scientific (TMO) Oncomine Dx Test Gains FDA Approval for NSCLC Treatment

August 12 at 4:28 PM | finance.yahoo.com

Thermo Fisher Scientific Inc. (NYSE:TMO) Stake Boosted by AGF Management Ltd.

August 12 at 8:16 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

LGV, TMO, ISRG, and IDXX Company Descriptions

IDEXX Laboratories NASDAQ:IDXX

$653.95 -9.97 (-1.50%)

Closing price 04:00 PM Eastern

Extended Trading

$649.16 -4.79 (-0.73%)

As of 07:10 PM Eastern

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Intuitive Surgical NASDAQ:ISRG

$477.08 -5.27 (-1.09%)

Closing price 04:00 PM Eastern

Extended Trading

$476.18 -0.90 (-0.19%)

As of 07:59 PM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Longview Acquisition Corp. II NYSE:LGV

Longview Acquisition Corp. II does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on businesses in the healthcare, industrials, consumer, media, technology, and technology services sector. The company was incorporated in 2020 and is based in New York, New York.

Thermo Fisher Scientific NYSE:TMO

$485.62 +0.83 (+0.17%)

Closing price 03:59 PM Eastern

Extended Trading

$476.50 -9.12 (-1.88%)

As of 07:54 PM Eastern

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time